Natco Pharma Limited Approves Scheme of Arrangement, Subsidiary Incorporation, and Liquidation
March 24, 2026 – Natco Pharma Limited announced that its Board of Directors approved a Scheme of Arrangement and other corporate actions at a meeting held on March 24, 2026.The Scheme of Arrangement involves the demerger of the Agrochemicals business from Natco Pharma Limited into Natco Crop Health Sciences Limited, a wholly-owned subsidiary. Shareholders of Natco Pharma Limited will receive one equity share in Natco Crop Health Sciences Limited for every equity share held in Natco Pharma Limited. The Appointed Date for the Scheme is October 1, 2026.
The Board also approved the incorporation of a wholly-owned subsidiary in Nigeria, named Natco Pharma Nigeria Limited, with an investment of up to USD 100,000. Additionally, the company plans to liquidate Natco Pharma Australia PTY Ltd., also a wholly-owned subsidiary.
The turnover of the Agrochemicals business for the year ending March 31, 2025, was ₹60,62,03,918, representing 1.48% of Natco Pharma Limited's total turnover. Subsequent to the Scheme becoming effective, Natco Crop Health Sciences Limited will seek listing on the BSE Limited and the National Stock Exchange of India Limited.
Source:
Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.